![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
The item has been added to your shopping cart.
Home » PFIZER JAPAN LAUNCHES J ZOLOFT TABLETS SSRI ANTIDEPRESSANT
PFIZER JAPAN LAUNCHES J ZOLOFT TABLETS SSRI ANTIDEPRESSANT
July 10, 2006
Pfizer Japan introduced J ZOLOFT Tablets 25mg/50mg, its proprietary antidepressant, on July 7. J ZOLOFT, which is a selective serotonin reuptake inhibitor (SSRI) developed by Pfizer of the US, was initially approved in the UK in 1990, and is now available in 110 countries worldwide.
JCNnetwork (http://www.japancorp.net/Article.Asp?Art_ID=12859)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct